Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

1,2-hexandiol can be absorbed well mainly via oral and dermal exposure (80% absorption assumed). The absorption via inhalation is considered irrelevant due to negligible exposure (i.e. low vapour pressure). No accumulation in the body is expected due to efficient metabolic pathways and formation of soluble degradation products with established elimination routes. 

Key value for chemical safety assessment

Bioaccumulation potential:
no bioaccumulation potential

Additional information

Based on available information, it is expected that 1,2-hexandiol can be absorbed well mainly via oral and dermal exposure (80% absorption assumed). The absorption via inhalation is considered irrelevant due to negligible exposure (i.e. low vapour pressure). Following absorption1,2-hexandiol is expected to be detoxified mainly through oxidation and conjugation. 1,2-Hexandiol and metabolites are proposed to distribute rapidly, mainly in blood, liver and kidney, while a large fraction may be excreted quickly via urine, in the form of glucuronide conjugation and parent compound. No accumulation in the body is expected due to efficient metabolic pathways and formation of soluble degradation products (glucose derivatives) with established elimination routes.